Estimated visceral adiposity is associated with risk of cardiometabolic conditions in a population based study

[HeartDoc Andrew]

Abstract

Visceral adiposity is a major risk factor of cardiometabolic diseases.
Visceral adipose tissue (VAT) is usually measured with expensive
imaging techniques which present financial and practical challenges to
population-based studies. We assessed whether cardiometabolic
conditions were associated with VAT by using a new and easily
measurable anthropometric index previously published and validated.
Data (1529 participants) came from the European Health Examination
Survey in Luxembourg (2013–2015). Logistic regressions were used to
study associations between VAT and cardiometabolic conditions. We
observed an increased risk of all conditions associated with VAT. The
total adjusted odds ratio (AOR, [95% CI]) for hypertension,
prediabetes/diabetes, hypercholesterolemia, and hypertriglyceridemia
for the fourth quartile of VAT compared to the lowest were 10.22
[6.75, 15.47]), (5.90 [4.02, 8.67]), (3.60 [2.47, 5.25]) and (7.67
[5.04, 11.67]. We observed higher odds in women than in men for all
outcomes with the exception of hypertension. Future studies should
investigate the impact of VAT changes on cardiometabolic health and
the use of anthropometrically predicted VAT as an accurate outcome
when no biomedical imaging is available.

Nature Journal link to abstract & article:
https://www.nature.com/articles/s41598-021-88587-9

Suggested further information about exactly how to lose the VAT can be
found at heartmdphdDOTcom